Compare FLL & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLL | ZTEK |
|---|---|---|
| Founded | 1987 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.8M | 68.8M |
| IPO Year | 2014 | 2022 |
| Metric | FLL | ZTEK |
|---|---|---|
| Price | $2.71 | $0.55 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 97.7K | 45.1K |
| Earning Date | 05-07-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $302,376,000.00 | N/A |
| Revenue This Year | $7.54 | N/A |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3.53 | N/A |
| 52 Week Low | $2.02 | $0.50 |
| 52 Week High | $4.95 | $1.84 |
| Indicator | FLL | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 63.82 | 41.44 |
| Support Level | $2.55 | $0.55 |
| Resistance Level | $2.90 | $0.75 |
| Average True Range (ATR) | 0.14 | 0.04 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 95.83 | 47.08 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins. Geographically, it operates in United States.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.